Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs

Activation of one or both the Ras/MAPK and PI3K/Akt/mTOR signal transduction pathways are known to mediate oncogenicity of several canine and human cancers, including mucosal melanomas. Reciprocal cross activation between the two pathways can be a source of drug resistance. Consequently, oral dosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Bih-Rong, Peer, Cody J., Richardson, William J., Hewitt, Stephen M., Figg, William D., Simpson, R. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794608/
https://www.ncbi.nlm.nih.gov/pubmed/36590793
http://dx.doi.org/10.3389/fvets.2022.1056408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794608/
https://www.ncbi.nlm.nih.gov/pubmed/36590793
http://dx.doi.org/10.3389/fvets.2022.1056408

Ejemplares similares